The global ultrasonic aspirator market was valued at approximately $440 million in 2025. The market is expected to grow at a compound annual growth rate (CAGR) of 3.5%, reaching approximately $557 million by 2032.
This report covers capital equipment, disposable probe tips, disposable tubing, handpieces, and accessories across the global ultrasonic aspirator market. The report quantifies procedure numbers, unit sales, average selling prices (ASPs), market values, growth rates, and company shares, with historical data back to 2022 and forecasts through 2032.
Tumor removal is a primary driver of the ultrasonic aspirator market, as these devices enable selective targeting of cancerous tissue while preserving surrounding nerves and blood vessels. This capability makes them particularly valuable in complex neurosurgical and highly vascular anatomical settings. Market growth is supported by a steady replacement cycle of approximately five to seven years for capital equipment, and by expanding clinical adoption in non-neurosurgical specialties where ultrasonic aspiration offers meaningful advantages in dissection of highly vascular organs.
The market is mature and near-saturated in its primary neurosurgical base, with essentially all facilities that perform neurosurgery already equipped with an ultrasonic aspirator. Penetration into adjacent surgical specialties including general surgery, gynecology, gastroenterology, and orthopedics represents the primary avenue for unit volume growth beyond the replacement cycle, with the disposable tip segment particularly active as specialized tip designs for diverse applications are developed and adopted.
The market is mature at the system level within its core neurosurgical base. Essentially all facilities that perform neurosurgery are already equipped with an ultrasonic aspirator, making the replacement of aging systems the largest single driver of capital equipment sales. The typical replacement cycle of five to seven years provides a predictable and sustained revenue base for manufacturers, but limits the opportunity for incremental system placements within the existing neurosurgical customer base. This dynamic defines a market where capital equipment growth is structurally constrained and where innovation and commercial focus have increasingly shifted toward expanding indications and the disposable product segments.
Non-neurosurgical applications represent the most meaningful source of new system placement opportunity. Ultrasonic aspirators are applicable to the dissection of tumors in the liver, kidney, and spleen and to procedures in other highly vascular organs, and their potential value has been recognized across specialties including general surgery, gynecology, cardiology, gastroenterology, and orthopedics. This expansion into adjacent specialties is driving broader hospital department adoption and is particularly reflected in the disposable tip market, where a growing variety of specialized tip designs for soft tissue and bone applications is supporting incremental consumable revenue per system.
The disposable product segments, including probe tips, tubing, and accessories, provide a recurring revenue stream that supports market value growth beyond what capital equipment placements alone would generate. As the installed base of systems grows and shifts toward multi-specialty use, the volume of disposables consumed per system per year increases, creating a compounding effect on consumable revenue that partially offsets the growth ceiling imposed by near-full penetration in the neurosurgical capital equipment segment.
Integra LifeSciences was the second-leading competitor in the ultrasonic aspirator market in 2025, supported by its long-established CUSA platform, which is known for precision and reliability in neurosurgical tissue removal. The CUSA Clarity system enhances performance with advanced tissue removal capabilities and integrated technologies that support adoption in leading academic neurosurgical programs. Integra's heritage in the CUSA brand, combined with ongoing platform development, has sustained its position as the primary alternative to Stryker in the high-acuity neurosurgical segment.
Bioventus was the third-leading competitor in the ultrasonic aspirator market in 2025. The company's Nexus platform combines ultrasonic aspiration, bone cutting, and wound debridement capabilities in an integrated surgical solution, enhancing procedural versatility and efficiency across a range of surgical applications. Bioventus's multi-modality approach differentiates the Nexus platform from single-modality aspirator systems and positions the company to capture adoption in surgical settings where the combination of tissue aspiration and bone management capabilities in a single system provides workflow and economic advantages.
5 charts and 43 figures illustrating market segmentation and performance metrics.
Methodology Appendix, Abbreviation and Acronym Glossary explaining all data definitions and modeling assumptions.
Licensing options: single-user, site, and enterprise.
This report covers capital equipment, disposable probe tips, disposable tubing, handpieces, and accessories across the global ultrasonic aspirator market. The report quantifies procedure numbers, unit sales, average selling prices (ASPs), market values, growth rates, and company shares, with historical data back to 2022 and forecasts through 2032.
Tumor removal is a primary driver of the ultrasonic aspirator market, as these devices enable selective targeting of cancerous tissue while preserving surrounding nerves and blood vessels. This capability makes them particularly valuable in complex neurosurgical and highly vascular anatomical settings. Market growth is supported by a steady replacement cycle of approximately five to seven years for capital equipment, and by expanding clinical adoption in non-neurosurgical specialties where ultrasonic aspiration offers meaningful advantages in dissection of highly vascular organs.
The market is mature and near-saturated in its primary neurosurgical base, with essentially all facilities that perform neurosurgery already equipped with an ultrasonic aspirator. Penetration into adjacent surgical specialties including general surgery, gynecology, gastroenterology, and orthopedics represents the primary avenue for unit volume growth beyond the replacement cycle, with the disposable tip segment particularly active as specialized tip designs for diverse applications are developed and adopted.
Market Overview
Ultrasonic aspirators use high-frequency vibration to selectively fragment and aspirate tissue, enabling surgeons to remove tumor masses and other target tissue with a high degree of precision while minimizing damage to adjacent nerves, blood vessels, and healthy parenchyma. This capability is particularly valuable in neurosurgery, where complex tumor resections in the brain and spinal cord require precise tissue management in anatomically critical and highly vascular regions. Continued demand for advanced tumor removal procedures, along with interest in capabilities such as bone shaving and fine dissection offered by leading platforms, supports steady market expansion across the forecast period.The market is mature at the system level within its core neurosurgical base. Essentially all facilities that perform neurosurgery are already equipped with an ultrasonic aspirator, making the replacement of aging systems the largest single driver of capital equipment sales. The typical replacement cycle of five to seven years provides a predictable and sustained revenue base for manufacturers, but limits the opportunity for incremental system placements within the existing neurosurgical customer base. This dynamic defines a market where capital equipment growth is structurally constrained and where innovation and commercial focus have increasingly shifted toward expanding indications and the disposable product segments.
Non-neurosurgical applications represent the most meaningful source of new system placement opportunity. Ultrasonic aspirators are applicable to the dissection of tumors in the liver, kidney, and spleen and to procedures in other highly vascular organs, and their potential value has been recognized across specialties including general surgery, gynecology, cardiology, gastroenterology, and orthopedics. This expansion into adjacent specialties is driving broader hospital department adoption and is particularly reflected in the disposable tip market, where a growing variety of specialized tip designs for soft tissue and bone applications is supporting incremental consumable revenue per system.
The disposable product segments, including probe tips, tubing, and accessories, provide a recurring revenue stream that supports market value growth beyond what capital equipment placements alone would generate. As the installed base of systems grows and shifts toward multi-specialty use, the volume of disposables consumed per system per year increases, creating a compounding effect on consumable revenue that partially offsets the growth ceiling imposed by near-full penetration in the neurosurgical capital equipment segment.
Market Drivers
Replacement Business
The replacement of aging ultrasonic aspirator systems is the largest single driver of unit sales in the capital equipment segment. Ultrasonic aspirators have a typical replacement cycle of approximately five to seven years, creating a predictable and recurring demand base that sustains market volume independent of new facility adoption. As the global installed base of systems ages and facilities upgrade to current-generation platforms with improved performance, precision, and integration capabilities, replacement sales will continue to drive capital equipment revenue. While this replacement dynamic does not expand the total number of installed systems, it supports sustained manufacturer revenue and provides commercial opportunities to upgrade customers to higher-priced systems with expanded functionality such as bone shaving, advanced dissection modes, and integrated aspiration controls.Expanded Indications
Penetration into non-neurosurgical hospital departments represents the primary opportunity for new system placements and incremental unit volume growth beyond the replacement cycle. Ultrasonic aspirators have established clinical utility in the dissection of tumors in highly vascular organs including the liver, kidney, and spleen, and their application is expanding across general surgery, gynecology, cardiology, gastroenterology, and orthopedics. This broadening of the clinical indication base is expanding the addressable customer base beyond neurosurgery departments and is driving particular growth in the disposable probe tip market, where a growing range of specialized tips for soft tissue and bone procedures has been developed to address the unique requirements of each specialty application. As clinical familiarity with ultrasonic aspiration grows across these adjacent specialties, new system placements and associated consumable adoption are expected to increase.Market Limiters
Market Saturation
The ultrasonic aspirator market is mature and heavily saturated within its primary neurosurgical customer base, which severely limits the potential for new system placements in established markets. Essentially all facilities that perform neurosurgical procedures are already equipped with an ultrasonic aspirator, meaning that the neurosurgical segment is effectively a pure replacement business with no meaningful opportunity for incremental unit growth from new customer acquisition. Technological advancement in the core product category has also slowed considerably compared to earlier periods of market development, reducing the pace of product-driven upgrade cycles and limiting ASP growth from feature premiums. The commercial viability of the market therefore depends primarily on the replacement cycle for existing installations, expansion into adjacent non-neurosurgical specialties, and growth in the consumable and accessories segments rather than on growth in the core capital equipment penetration rate.Market Coverage and Data Scope
- Quantitative coverage: Procedure numbers, market size, market shares, market forecasts, growth rates, units sold, and average selling prices.
- Qualitative coverage: Growth trends, market limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles and product portfolios, and technology trends shaping demand.
- Time frame: Base year 2025, forecasts 2026 to 2032, historical data 2022 to 2024.
- Data sources: Primary interviews with neurosurgical device industry leaders and surgeons, regulatory data, hospital procurement data, import and export data, and the iData Research internal database.
- Care settings: Hospitals, academic medical centers, neurosurgical specialty centers, and general and specialty surgical facilities.
Markets Covered and Segmentation
The ultrasonic aspirator market is analyzed across five product categories, each assessed by procedure volume, unit volume, ASP, and market value with historical and forecast data:
- Capital Equipment
- Disposable Probe Tips
- Disposable Tubing
- Handpieces
- Accessories
Competitive Analysis
Stryker was the leading competitor in the ultrasonic aspirator market in 2025, driven by its Sonopet product line offering multiple handpiece and tip configurations for both soft tissue and bone applications. The Sonopet iQ system enhances surgical precision and procedural efficiency through integrated fragmentation, emulsification, and aspiration capabilities, serving neurosurgery, spine, and ENT applications. Stryker's market leadership is supported by its broad neurosurgical commercial presence and its ability to position the Sonopet platform as part of an integrated suite of neurosurgical capital equipment and instruments.Integra LifeSciences was the second-leading competitor in the ultrasonic aspirator market in 2025, supported by its long-established CUSA platform, which is known for precision and reliability in neurosurgical tissue removal. The CUSA Clarity system enhances performance with advanced tissue removal capabilities and integrated technologies that support adoption in leading academic neurosurgical programs. Integra's heritage in the CUSA brand, combined with ongoing platform development, has sustained its position as the primary alternative to Stryker in the high-acuity neurosurgical segment.
Bioventus was the third-leading competitor in the ultrasonic aspirator market in 2025. The company's Nexus platform combines ultrasonic aspiration, bone cutting, and wound debridement capabilities in an integrated surgical solution, enhancing procedural versatility and efficiency across a range of surgical applications. Bioventus's multi-modality approach differentiates the Nexus platform from single-modality aspirator systems and positions the company to capture adoption in surgical settings where the combination of tissue aspiration and bone management capabilities in a single system provides workflow and economic advantages.
Technology and Practice Trends
- Multi-modality platform integration: Systems combining ultrasonic aspiration with bone cutting and wound debridement in a single platform, such as the Bioventus Nexus, are expanding the procedural versatility of ultrasonic aspirator capital equipment and broadening adoption beyond core neurosurgical applications.
- Bone shaving and fine dissection capabilities: Interest in advanced functionalities including bone shaving and fine dissection offered by platforms such as the CUSA and Sonopet systems is supporting upgrades and new placements where precision tissue management in bone-adjacent or vascular anatomy is required.
- Specialized disposable tip designs: A growing variety of probe tips designed for soft tissue, bone, and specialty organ applications is expanding the consumable revenue opportunity per installed system and driving growth in the disposable tip market across both neurosurgical and non-neurosurgical applications.
- Non-neurosurgical specialty expansion: Clinical adoption of ultrasonic aspiration in general surgery, gynecology, gastroenterology, cardiology, and orthopedics is the primary avenue for new system placements, with each specialty requiring tailored tip designs and procedural configurations.
- Precision and efficiency improvements: Advances in handpiece ergonomics, aspiration control, and tissue fragmentation modes are improving procedural outcomes and shortening operating room time, supporting the economic case for system upgrades within existing customers.
- Replacement cycle management: With replacement cycles of five to seven years and a near-saturated neurosurgical installed base, manufacturers are focusing on early engagement with existing customers and differentiating on performance features to drive timely and premium upgrades.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.Deliverables
77 pages of detailed narrative analysis, tables, and figures.5 charts and 43 figures illustrating market segmentation and performance metrics.
Methodology Appendix, Abbreviation and Acronym Glossary explaining all data definitions and modeling assumptions.
Licensing options: single-user, site, and enterprise.
Why This Report
- Where are the largest and fastest-growing opportunities across capital equipment, disposable tips, tubing, handpieces, and accessories within the global ultrasonic aspirator market through 2032?
- How is the replacement cycle dynamic shaping capital equipment sales, and what platform features are driving premium upgrades within the existing installed base?
- Which non-neurosurgical specialties are most actively adopting ultrasonic aspiration, and how is this expansion driving growth in the disposable probe tip segment?
- How are multi-modality platforms combining aspiration, bone cutting, and debridement in a single system changing the competitive landscape and purchasing criteria for surgical facilities?
- Which companies lead the market and how are the Sonopet iQ, CUSA Clarity, and Nexus platforms differentiated by capability, application, and commercial positioning?
- What is the outlook for each of the five product categories, and how do capital equipment replacement cycles interact with consumable adoption rates to shape total market revenue?
- How does near-full neurosurgical market saturation shape the commercial strategy priorities of leading manufacturers, and where are the remaining opportunities for new system placements?
- What are the key risks to market growth, including slowing technological advancement, pricing pressure, saturation in core markets, and the pace of non-neurosurgical specialty adoption?
Table of Contents
Research Methodology
Ultrasonic Aspirator Market
List of Charts
List of Figures
